International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 4

Can Machine Learning Resolve Ambiguous Natural Product Structures Using Spectroscopic Evidence, Molecular Constraints, Candidate Ranking, and Automated Structure Elucidation?
Download PDF


, ,
  1. Department of ML-Assisted Structure Elucidation, Faculty of Pharmacy, Karolinska Institute, Stockholm, Sweden.
  2. Department of Spectroscopic Evidence and Candidate Ranking, Faculty of Pharmacy, Lund University, Lund, Sweden.
Citation
Vancouver
Nilsson P, Johansson E, Andersson L. Can Machine Learning Resolve Ambiguous Natural Product Structures Using Spectroscopic Evidence, Molecular Constraints, Candidate Ranking, and Automated Structure Elucidation? Int J Pharm Phytopharmacol Res. 2025;15(4):103-12. https://doi.org/10.51847/i96x23Gau3
APA
Nilsson, P., Johansson, E., & Andersson, L. (2025). Can Machine Learning Resolve Ambiguous Natural Product Structures Using Spectroscopic Evidence, Molecular Constraints, Candidate Ranking, and Automated Structure Elucidation? International Journal of Pharmaceutical And Phytopharmacological Research, 15(4), 103-112. https://doi.org/10.51847/i96x23Gau3
Download citation:   EndNote   RIS
Article Link:
Downloads: 28
Views: 87
Abstract

Natural-product structure elucidation remains a challenging inference problem because spectroscopic evidence is often incomplete, noisy, or nonunique, requiring reconciliation with molecular formulae, chemical plausibility, and stereochemical alternatives. Machine learning has increasingly been applied across this workflow, yet the term "identification" encompasses heterogeneous tasks from peak interpretation and formula prediction to full-structure generation. This scoping review mapped peer-reviewed evidence published from 2017 to 2025 concerning machine-learning-assisted structure inference for natural products and small molecules using NMR, tandem mass spectrometry, infrared, UV, and multimodal spectral data. Following a PRISMA-ScR-compatible evidence-mapping approach, we charted analytical modalities, prediction tasks, molecular constraints, candidate-generation strategies, ranking methods, validation designs, uncertainty treatments, and transferability limits. The mapped literature reveals a distributed automation landscape rather than a single solved workflow. NMR-based methods increasingly extract structure-sensitive constraints, mass-spectral approaches narrow formula and candidate spaces while inferring classes and fingerprints, and infrared or multimodal models contribute orthogonal evidence. Probabilistic and learned scoring systems prioritize competing candidates effectively. However, exact two-dimensional structure recovery, stereochemical assignment, confidence calibration, candidate-set completeness, and out-of-domain transfer remain distinct unresolved challenges. We therefore propose a constrained-inference interpretation in which machine learning progressively reduces ambiguity through staged constraint extraction and candidate prioritization, rather than replacing structural proof with a single model score. Current evidence supports machine learning as a powerful assistive tool, but fully autonomous natural-product identification is not yet universally achievable.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.